Genetic determinants of plasma HDL-cholesterol levels in prepubertal children. 2009

Laura López-Simón, and Manuel de Oya, and Miguel A Lasunción, and Pía Riestra, and Mercedes Benavente, and Iría de Oya, and Beatriz Cano, and Stefanie Schoppen, and Carmen Garcés
Lipid Research Laboratory, Fundación Jiménez Díaz, Avda. Reyes Católicos, 2, 28040 Madrid, Spain.

BACKGROUND Genetic determinants have been related to variation of high-density lipoprotein cholesterol (HDL-C) levels, but the extension of this association remains controversial. In our study, we analyzed the contribution of several polymorphisms on HDL-C-related genes to variation of plasma HDL-C in prepubertal children. METHODS We studied 1269 (641 males and 628 females) 6-8 years old healthy children, who participated in a cross-sectional study examining cardiovascular risk factors in Spain. Common genetic variants in the apolipoprotein AI, apolipoprotein AII, cholesteryl ester transfer protein (CETP), hepatic lipase, ATP-binding cassette transporter A1, and paraoxonase genes were determined by PCR. RESULTS CETP TaqI B2 carrier girls had significantly higher HDL-C levels than B1B1 girls. B2B2 boys had significantly higher (p<0.001) HDL-C than B1B1and B1B2 boys. In linear regression analysis, CETP TaqIB appears as the main predictor of HDL-C plasma levels, accounting for 4.5% and 1.8% of HDL-C variation in girls and boys respectively. CONCLUSIONS Our data showed that among the studied polymorphisms only the CETP TaqIB polymorphism contributes to the variation in HDL-C levels in prepubertal children, particularly in girls, but overall these polymorphisms explain a small part of the variation of HDL-C plasma levels at this age.

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011627 Puberty A period in the human life in which the development of the hypothalamic-pituitary-gonadal system takes place and reaches full maturity. The onset of synchronized endocrine events in puberty lead to the capacity for reproduction (FERTILITY), development of secondary SEX CHARACTERISTICS, and other changes seen in ADOLESCENT DEVELOPMENT. Puberties
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Laura López-Simón, and Manuel de Oya, and Miguel A Lasunción, and Pía Riestra, and Mercedes Benavente, and Iría de Oya, and Beatriz Cano, and Stefanie Schoppen, and Carmen Garcés
October 2005, European journal of human genetics : EJHG,
Laura López-Simón, and Manuel de Oya, and Miguel A Lasunción, and Pía Riestra, and Mercedes Benavente, and Iría de Oya, and Beatriz Cano, and Stefanie Schoppen, and Carmen Garcés
May 1980, Atherosclerosis,
Laura López-Simón, and Manuel de Oya, and Miguel A Lasunción, and Pía Riestra, and Mercedes Benavente, and Iría de Oya, and Beatriz Cano, and Stefanie Schoppen, and Carmen Garcés
July 2007, Nihon rinsho. Japanese journal of clinical medicine,
Laura López-Simón, and Manuel de Oya, and Miguel A Lasunción, and Pía Riestra, and Mercedes Benavente, and Iría de Oya, and Beatriz Cano, and Stefanie Schoppen, and Carmen Garcés
March 1983, International journal of epidemiology,
Laura López-Simón, and Manuel de Oya, and Miguel A Lasunción, and Pía Riestra, and Mercedes Benavente, and Iría de Oya, and Beatriz Cano, and Stefanie Schoppen, and Carmen Garcés
July 2006, Current opinion in cardiology,
Laura López-Simón, and Manuel de Oya, and Miguel A Lasunción, and Pía Riestra, and Mercedes Benavente, and Iría de Oya, and Beatriz Cano, and Stefanie Schoppen, and Carmen Garcés
April 2013, Arteriosclerosis, thrombosis, and vascular biology,
Laura López-Simón, and Manuel de Oya, and Miguel A Lasunción, and Pía Riestra, and Mercedes Benavente, and Iría de Oya, and Beatriz Cano, and Stefanie Schoppen, and Carmen Garcés
June 1992, Journal of internal medicine,
Laura López-Simón, and Manuel de Oya, and Miguel A Lasunción, and Pía Riestra, and Mercedes Benavente, and Iría de Oya, and Beatriz Cano, and Stefanie Schoppen, and Carmen Garcés
March 1982, Quaderni Sclavo di diagnostica clinica e di laboratorio,
Laura López-Simón, and Manuel de Oya, and Miguel A Lasunción, and Pía Riestra, and Mercedes Benavente, and Iría de Oya, and Beatriz Cano, and Stefanie Schoppen, and Carmen Garcés
December 2004, Nature clinical practice. Cardiovascular medicine,
Laura López-Simón, and Manuel de Oya, and Miguel A Lasunción, and Pía Riestra, and Mercedes Benavente, and Iría de Oya, and Beatriz Cano, and Stefanie Schoppen, and Carmen Garcés
April 2019, Current opinion in lipidology,
Copied contents to your clipboard!